Non-invasive prenatal testing (NIPT), currently the most routine genetic test offered to public, has been offered by various private and public groups over-time, while many details change the fast-turnaround time is one of the test’s more valuable assets. UZ Leuven has been the torch bearer, implementing a novel pipeline which was validated end of 2013 and made available to the clinicians. In July 2018 Belgium passed the bill offering this test thru the public healthcare system causing a surge in the number of samples. We will walk thru the subsequent actions taken to automate and streamline the process to keep up with the numbers.
Baran Bayindir, UZ Leuven